HCA Healthcare, Inc.: EPS $7.22 vs $6.65 expected; revenue $19.9B vs $19.3B
Key Facts
Q3 FY2026 results
| Metric | Actual | Estimate | Surprise | Year ago |
|---|---|---|---|---|
| EPS (USD) | 7.22 | 6.65 | +8.6% | 6.96 |
| Revenue (USD bn) | 19.85 | 19.33 | +2.7% | 19.16 |
Recent reports: actual vs estimate
| Reported | Period | EPS (USD) | Estimate | Surprise | Revenue (USD bn) | Estimate | Surprise |
|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | Q3 FY2026 | 7.22 | 6.65 | +8.6% | 19.85 | 19.33 | +2.7% |
| Jul 24, 2026 | Q2 FY2026 | 7.59 | 7.56 | +0.4% | 20.23 | 19.76 | +2.4% |
| Apr 24, 2026 | Q1 FY2026 | 7.15 | 7.12 | +0.4% | 19.11 | 19.09 | +0.1% |
| Jan 27, 2026 | Q4 FY2025 | 8.01 | 7.46 | +7.4% | 19.51 | 19.68 | −0.9% |
| Oct 24, 2025 | Q3 FY2025 | 6.96 | 5.79 | +20.2% | 19.16 | 18.60 | +3.0% |
| Jul 25, 2025 | Q2 FY2025 | 6.84 | 6.29 | +8.7% | 18.61 | 18.50 | +0.6% |
| Apr 25, 2025 | Q1 FY2025 | 6.45 | 5.75 | +12.2% | 18.32 | 18.26 | +0.3% |
| Jan 24, 2025 | Q4 FY2024 | 6.22 | 6.13 | +1.5% | 18.29 | 18.23 | +0.3% |
Source: Figures from the EL7 database. Estimates are the analyst consensus carried by our data vendor (FMP), not official figures.
HCA Healthcare, Inc. results: EPS $7.22 vs $6.65 expected; revenue $19.9B vs $19.3B. The results cover the company's Q3 FY2026. EPS came in above analysts' estimate by 8.6%; revenue above the estimate by 2.7%.
Revenue was up 3.6% from $19.2 billion a year earlier (Q3 FY2025). EPS was up 3.7% from $6.96 a year earlier. On its record, EPS topped analysts' estimates in 7 of 7 earlier comparable reports.
What the results mean
HCA Healthcare, Inc. operates a network combining hospitals and outpatient facilities, allowing it to provide services across varied treatment settings. Revenue growth points to expanding business activity, but the available material does not establish how much service volume or service mix contributed to that growth.
Understanding the company's performance requires attention to the distribution of activity across inpatient care, surgery, emergency services and outpatient care. This service breadth makes case mix and care intensity important to understanding the relationship between revenue and treatment costs, although the available material does not identify their respective contributions to profitability.
What to watch on the earnings call: The earnings call merits attention to management's discussion of demand across hospitals and outpatient facilities, and the roles of service volume and case mix in revenue growth. Discussion of care delivery costs and facility spending would also help explain how business activity translates into margins.
For the full analysis of HCA Healthcare, Inc. stock — valuation, scores and financial statements — see the stock page linked with this story.